Chanelle Pharmaceuticals Sold for €300m

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 23 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 77%

Business News

Chanelle Pharmaceuticals,Michael Burke,Sale

Vet turned businessman Michael Burke has sold the Chanelle Pharmaceuticals he founded over 40 years ago for a figure understood to be around €300 million. British private equity group Exponent will take over the business which Mr Burke put on the market through investment bank Rothschild last year.

Vet turned businessman Michael Burke has sold the Chanelle Pharmaceuticals he founded over 40 years ago for a figure understood to be around €300 million. British private equity group Exponent will take over the business which Mr Burke put on the market through investment bank Rothschild last year. The company’s 730 staff were briefed on Wednesday on the takeover of the business, the largest producer of generic medications for humans and animals in the State.

“Having dedicated my life to building Chanelle Pharma into a global company, I have decided the time is right to allow new owners to lead the company into its next phase of growth,” Mr Burke said. “I am very pleased that Exponent is acquiring Chanelle Pharma. They value the heritage of our company and share our ethos and vision. They have the expertise and resources to grow Chanelle Pharma with new investment across all our operation

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Galway-based Channelle Pharma to be sold for €300mGalway-based generic drugmaker Channelle Pharma is on track to be sold to UK private equity firm Exponent in a deal said to be worth about €300 million. The company has veterinary and human drug licenses in the EU. Other private equity firms were also interested in the bidding process. Channelle Pharma is estimated to make a profit of about €25 million a year.
Source: IrishTimesBiz - 🏆 6. / 77 Read more »